ondansetron has been researched along with Hyperdactyly in 1 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ondansetron is an antagonist of 5-HT3 receptors mostly used as an antiemetic yet known to modulate metabolism and appetite." | 1.38 | Differential effects of 5-HT3 receptor antagonist on lipid profile in spontaneously hypertensive rat and chromosome 8 congenic strain. ( Kren, V; Krenova, D; Krupkova, M; Liska, F; Seda, O; Sedova, L, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Krupkova, M | 1 |
| Sedova, L | 1 |
| Liska, F | 1 |
| Krenova, D | 1 |
| Kren, V | 1 |
| Seda, O | 1 |
1 other study available for ondansetron and Hyperdactyly
| Article | Year |
|---|---|
Differential effects of 5-HT3 receptor antagonist on lipid profile in spontaneously hypertensive rat and chromosome 8 congenic strain.
Topics: Animals; Animals, Congenic; Chromosomes, Mammalian; Disease Models, Animal; Glucose Intolerance; Hyp | 2012 |